Quick Answer
Viking Therapeutics, Inc. reported Total Assets of $715.73 million for fiscal year 2025.
Viking Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $715.73M | -21.2% |
| 2024 | $908.32M | +146.5% |
| 2023 | $368.49M | +118.7% |
| 2022 | $168.53M | -20.0% |
| 2021 | $210.66M | -17.9% |
| 2020 | $256.50M | -9.8% |
| 2019 | $284.26M | -6.0% |
| 2018 | $302.31M | +1266.6% |
| 2017 | $22.12M | +52.2% |
| 2016 | $14.54M | -5.9% |
| 2015 | $15.44M | +407.3% |
| 2014 | $3.04M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $739.41M | -21.2% | -10.7% |
| June 30, 2025 | $827.85M | -12.6% | -4.5% |
| March 31, 2025 | $866.99M | -10.4% | -4.5% |
| December 31, 2024 | $908.32M | +146.5% | -3.2% |
| September 30, 2024 | $937.89M | +145.1% | -0.9% |
| June 30, 2024 | $946.84M | +136.3% | -2.1% |
| March 31, 2024 | $967.52M | +541.2% | +162.6% |
| December 31, 2023 | $368.49M | +118.7% | -3.7% |
- Viking Therapeutics, Inc. showed a decrease of -21.2% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Viking Therapeutics, Inc.’s total assets has grown by 23419.5% (from $3.04 million to $715.73 million).
- The most recent figure is from Viking Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: